Susquehanna International Group, LLP My Md Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$0.22 - $0.58 $660 - $1,739	3,000 Added 13.22%	25,700 $6,000
Q3 2023 Nov 14, 2023	BUY	$0.47 - $1.87 $4,230 - $16,830	9,000 Added 65.69%	22,700 $13,000
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.26 $19,728 - $30,961	13,700 New	13,700 $20,000
Q1 2022 May 16, 2022	SELL	$3.34 - $6.05 $184,034 - $333,355	-55,100 Reduced 78.49%	15,100 $70,000
Q4 2021 Feb 14, 2022	BUY	$5.46 - $9.69 $318,318 - $564,927	58,300 Added 489.92%	70,200 $425,000
Q3 2021 Nov 15, 2021	SELL	$4.64 - $7.94 $8,352 - $14,292	-1,800 Reduced 13.14%	11,900 $86,000
Q2 2021 Aug 11, 2021	BUY	$3.39 - $6.98 $46,443 - $95,626	13,700 New	13,700 $86,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.